These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 3885892

  • 1. Group B streptococcal infective endocarditis.
    Backes RJ, Wilson WR, Geraci JE.
    Arch Intern Med; 1985 Apr; 145(4):693-6. PubMed ID: 3885892
    [Abstract] [Full Text] [Related]

  • 2. Vancomycin therapy for infective endocarditis.
    Geraci JE, Wilson WR.
    Rev Infect Dis; 1981 Apr; 3 suppl():S250-8. PubMed ID: 7342289
    [Abstract] [Full Text] [Related]

  • 3. [Endocarditis caused by group B streptococci in adults].
    Marron A, Carratalà J, Peña C, Rosón B, Tubau F, Rufí G.
    Enferm Infecc Microbiol Clin; 1997 Mar; 15(3):147-50. PubMed ID: 9235055
    [Abstract] [Full Text] [Related]

  • 4. [Aminoglycosides in the treatment of infectious endocarditis].
    Malinverni R.
    Schweiz Med Wochenschr Suppl; 1996 Mar; 76():14S-20S. PubMed ID: 8677414
    [Abstract] [Full Text] [Related]

  • 5. Antibiotic treatment of infective endocarditis.
    Wilson WR, Geraci JE.
    Annu Rev Med; 1983 Mar; 34():413-27. PubMed ID: 6344769
    [Abstract] [Full Text] [Related]

  • 6. Infective endocarditis due to penicillin-resistant viridans group streptococci.
    Knoll B, Tleyjeh IM, Steckelberg JM, Wilson WR, Baddour LM.
    Clin Infect Dis; 2007 Jun 15; 44(12):1585-92. PubMed ID: 17516402
    [Abstract] [Full Text] [Related]

  • 7. Effect of penicillin resistance on presentation and outcome of nonenterococcal streptococcal infective endocarditis.
    Hsu RB, Lin FY.
    Cardiology; 2006 Jun 15; 105(4):234-9. PubMed ID: 16534200
    [Abstract] [Full Text] [Related]

  • 8. [Therapy and prevention of infectious endocarditis].
    Horstkotte D, Rosin H.
    Schweiz Med Wochenschr; 1984 Nov 10; 114(45):1575-86. PubMed ID: 6515354
    [Abstract] [Full Text] [Related]

  • 9. Synergistic treatment of enterococcal endocarditis: in vitro and in vivo studies.
    Serra P, Brandimarte C, Martino P, Carlone S, Giunchi G.
    Arch Intern Med; 1977 Nov 10; 137(11):1562-7. PubMed ID: 921443
    [Abstract] [Full Text] [Related]

  • 10. Activity of penicillin combined with an aminoglycoside against group B streptococci in vitro and in experimental endocarditis.
    Backes RJ, Rouse MS, Henry NK, Geraci JE, Wilson WR.
    J Antimicrob Chemother; 1986 Oct 10; 18(4):491-8. PubMed ID: 3771432
    [Abstract] [Full Text] [Related]

  • 11. Infective endocarditis caused by Streptococcus bovis resistant to the lethal effect of penicillin G.
    Savitch CB, Barry AL, Hoeprich PD.
    Arch Intern Med; 1978 Jun 10; 138(6):931-4. PubMed ID: 246729
    [Abstract] [Full Text] [Related]

  • 12. In vitro susceptibility of Streptococcus bovis to six antibiotics.
    Klein RS, Milazzo JJ, Edberg SC.
    Clin Ther; 1984 Jun 10; 6(4):518-23. PubMed ID: 6467280
    [Abstract] [Full Text] [Related]

  • 13. Bacterial endocarditis caused by vitamin B6-dependent viridans group Streptococcus.
    Feder HM, Olsen N, McLaughlin JC, Bartlett RC, Chameides L.
    Pediatrics; 1980 Aug 10; 66(2):309-12. PubMed ID: 7402819
    [Abstract] [Full Text] [Related]

  • 14. [Antibiotic sensitivity of Streptococcus group B].
    Borderon JC, Borderon E, Geslin P, Sissia G, Valla M.
    Pathol Biol (Paris); 1984 Jan 10; 32(1):35-9. PubMed ID: 6366705
    [Abstract] [Full Text] [Related]

  • 15. In vitro susceptibility of group G streptococci to ten antimicrobial agents with broad gram-positive spectra.
    Bayer AS, Lam K.
    Clin Ther; 1983 Jan 10; 5(4):391-7. PubMed ID: 6871922
    [Abstract] [Full Text] [Related]

  • 16. [Optimum choice of antibiotic treatment in neonatal infections due to group B streptococci].
    Bingen E, Lambert-Zechovsky N, Guihaire E, Mancy C, Aujard Y, Mathieu H.
    Pathol Biol (Paris); 1986 May 10; 34(5):530-3. PubMed ID: 3534738
    [Abstract] [Full Text] [Related]

  • 17. Chemotherapy of experimental streptococcal endocarditis. IV. Further observations on prophylaxis.
    Pelletier LL, Durack DT, Petersdorf RG.
    J Clin Invest; 1975 Aug 10; 56(2):319-30. PubMed ID: 1150874
    [Abstract] [Full Text] [Related]

  • 18. [Treatment with vancomycin of experimental endocarditis caused by Streptococcus sanguis II resistant to penicillin].
    Martínez F, Martín Luengo F, Valdés M.
    Enferm Infecc Microbiol Clin; 1993 May 10; 11(5):255-9. PubMed ID: 8324022
    [Abstract] [Full Text] [Related]

  • 19. Chemotherapy of experimental streptococcal endocarditis. II. Synergism between penicillin and streptomycin against penicillin-sensitive streptococci.
    Durack DT, Pelletier LL, Petersdorf RG.
    J Clin Invest; 1974 Mar 10; 53(3):829-33. PubMed ID: 4492776
    [Abstract] [Full Text] [Related]

  • 20. Streptococcal meningitis in adult patients: current epidemiology and clinical spectrum.
    Cabellos C, Viladrich PF, Corredoira J, Verdaguer R, Ariza J, Gudiol F.
    Clin Infect Dis; 1999 May 10; 28(5):1104-8. PubMed ID: 10452643
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.